,NR 507 Advanced Pathophysiology: Neurological
Disorders Questions, Answers, & Rationales
(2026/2027 Update)
Question 1: Parkinson Disease Pathophysiology
What primary neuropathological mechanism drives the motor
symptoms of Parkinson Disease?
A. Degeneration of dopaminergic neurons in the substantia
nigra pars compacta, resulting in dopamine depletion
within the striatum and imbalance between the direct and
indirect basal ganglia motor loops.
B. Autoimmune destruction of upper and lower motor
neurons throughout the brainstem and spinal cord.
C. Massive accumulation of neurofibrillary tangles and
amyloid-beta plaques exclusively within the hippocampus.
D. Ischemic infarction of the internal capsule and basal
ganglia secondary to middle cerebral artery occlusion.
Correct Answer: A. Degeneration of dopaminergic neurons
in the substantia nigra pars compacta, resulting in dopamine
depletion within the striatum and imbalance between the
direct and indirect basal ganglia motor loops.
Explanation: Parkinson disease is characterized by the
progressive loss of pigmented dopaminergic neurons in the
substantia nigra pars compacta and the intracellular
accumulation of alpha-synuclein protein aggregates (Lewy
bodies). Dopamine normally facilitates movement by exciting
the direct pathway and inhibiting the indirect pathway of the
basal ganglia. When dopamine levels drop sharply in the
,striatum, the indirect pathway becomes hyperactive, suppressing
movement and producing the core clinical triad of bradykinesia,
resting tremor, and rigidity.
Question 2: Multiple Sclerosis Pathophysiology
What is the primary underlying immunopathological process in
Multiple Sclerosis (MS)?
A. Autoimmune, T-cell-mediated inflammatory
demyelination and axonal injury within the central nervous
system, leading to sclerotic plaque formation and disrupted
nerve conduction.
B. Primary genetic degeneration of acetylcholine receptors
at the neuromuscular junction.
C. Viral destruction of lower motor neurons within the
anterior horn cells of the spinal cord.
D. Chronic metabolic deficiency of vitamin B12 causing
subacute combined degeneration of the dorsal columns.
Correct Answer: A. Autoimmune, T-cell-mediated
inflammatory demyelination and axonal injury within the
central nervous system, leading to sclerotic plaque formation
and disrupted nerve conduction.
Explanation: Multiple sclerosis is a chronic inflammatory
autoimmune disorder where autoreactive T-lymphocytes cross
the blood-brain barrier and attack myelin antigens. This immune
cascade activates microglia and macrophages, leading to the
destruction of the myelin sheath (demyelination) and underlying
axons within the white matter of the brain and spinal cord. The
, resulting scars or plaques slow or completely block electrical
impulse propagation, producing varied neurological deficits.
Question 3: Myasthenia Gravis Mechanism
What structural component of the neuromuscular junction is
targeted by autoantibodies in Myasthenia Gravis?
A. Postsynaptic nicotinic acetylcholine receptors, leading to
receptor degradation, complement-mediated damage, and
impaired neuromuscular transmission.
B. Presynaptic voltage-gated calcium channels, preventing
the exocytosis of acetylcholine vesicles.
C. Acetylcholine esterase enzymes within the synaptic
cleft.
D. Schwann cells responsible for peripheral nerve
myelination.
Correct Answer: A. Postsynaptic nicotinic acetylcholine
receptors, leading to receptor degradation, complement-
mediated damage, and impaired neuromuscular
transmission.
Explanation: Myasthenia gravis is an antibody-mediated
autoimmune disease directed against the nicotinic acetylcholine
receptors (AChR) on the postsynaptic membrane of skeletal
muscles. IgG autoantibodies bind to these receptors, causing
functional blockade, accelerating their destruction via
endocytosis, and activating complement-mediated lysis of the
postsynaptic folds. This drastically reduces the number of
functional receptors available, manifesting clinically as
Disorders Questions, Answers, & Rationales
(2026/2027 Update)
Question 1: Parkinson Disease Pathophysiology
What primary neuropathological mechanism drives the motor
symptoms of Parkinson Disease?
A. Degeneration of dopaminergic neurons in the substantia
nigra pars compacta, resulting in dopamine depletion
within the striatum and imbalance between the direct and
indirect basal ganglia motor loops.
B. Autoimmune destruction of upper and lower motor
neurons throughout the brainstem and spinal cord.
C. Massive accumulation of neurofibrillary tangles and
amyloid-beta plaques exclusively within the hippocampus.
D. Ischemic infarction of the internal capsule and basal
ganglia secondary to middle cerebral artery occlusion.
Correct Answer: A. Degeneration of dopaminergic neurons
in the substantia nigra pars compacta, resulting in dopamine
depletion within the striatum and imbalance between the
direct and indirect basal ganglia motor loops.
Explanation: Parkinson disease is characterized by the
progressive loss of pigmented dopaminergic neurons in the
substantia nigra pars compacta and the intracellular
accumulation of alpha-synuclein protein aggregates (Lewy
bodies). Dopamine normally facilitates movement by exciting
the direct pathway and inhibiting the indirect pathway of the
basal ganglia. When dopamine levels drop sharply in the
,striatum, the indirect pathway becomes hyperactive, suppressing
movement and producing the core clinical triad of bradykinesia,
resting tremor, and rigidity.
Question 2: Multiple Sclerosis Pathophysiology
What is the primary underlying immunopathological process in
Multiple Sclerosis (MS)?
A. Autoimmune, T-cell-mediated inflammatory
demyelination and axonal injury within the central nervous
system, leading to sclerotic plaque formation and disrupted
nerve conduction.
B. Primary genetic degeneration of acetylcholine receptors
at the neuromuscular junction.
C. Viral destruction of lower motor neurons within the
anterior horn cells of the spinal cord.
D. Chronic metabolic deficiency of vitamin B12 causing
subacute combined degeneration of the dorsal columns.
Correct Answer: A. Autoimmune, T-cell-mediated
inflammatory demyelination and axonal injury within the
central nervous system, leading to sclerotic plaque formation
and disrupted nerve conduction.
Explanation: Multiple sclerosis is a chronic inflammatory
autoimmune disorder where autoreactive T-lymphocytes cross
the blood-brain barrier and attack myelin antigens. This immune
cascade activates microglia and macrophages, leading to the
destruction of the myelin sheath (demyelination) and underlying
axons within the white matter of the brain and spinal cord. The
, resulting scars or plaques slow or completely block electrical
impulse propagation, producing varied neurological deficits.
Question 3: Myasthenia Gravis Mechanism
What structural component of the neuromuscular junction is
targeted by autoantibodies in Myasthenia Gravis?
A. Postsynaptic nicotinic acetylcholine receptors, leading to
receptor degradation, complement-mediated damage, and
impaired neuromuscular transmission.
B. Presynaptic voltage-gated calcium channels, preventing
the exocytosis of acetylcholine vesicles.
C. Acetylcholine esterase enzymes within the synaptic
cleft.
D. Schwann cells responsible for peripheral nerve
myelination.
Correct Answer: A. Postsynaptic nicotinic acetylcholine
receptors, leading to receptor degradation, complement-
mediated damage, and impaired neuromuscular
transmission.
Explanation: Myasthenia gravis is an antibody-mediated
autoimmune disease directed against the nicotinic acetylcholine
receptors (AChR) on the postsynaptic membrane of skeletal
muscles. IgG autoantibodies bind to these receptors, causing
functional blockade, accelerating their destruction via
endocytosis, and activating complement-mediated lysis of the
postsynaptic folds. This drastically reduces the number of
functional receptors available, manifesting clinically as
